Trial ID or NCT#





The purpose of this trial is to determine the safety and effectiveness of the Edwards SAPIEN XT and the Edwards SAPIEN 3 transcatheter heart valve and delivery systems which are intended for use in patients with symptomatic, calcific, severe aortic stenosis.

Official Title

The PARTNER II Trial "Placement of AoRTic TraNscathetER" Valves Trial" (US) [PII A]

Eligibility Criteria

Ages Eligible for Study: Older than 19 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No


D. Craig Miller, MD
Cardiovascular surgeon
Thelma and Henry Doelger Professor in Cardiovascular Surgery
Rajesh Dash, MD, PhD, Medical & Scientific Director, SSATHI
Assistant Professor of Medicine (Cardiovascular Medicine) at the Stanford University Medical Center
Alan Yeung, MD
Interventional cardiologist, Cardiologist
The Li Ka Shing Professor in Cardiology

Contact us to find out if this trial is right for you.


Leigh Trautman, RN
(650) 725-3931